<DOC>
	<DOCNO>NCT00699283</DOCNO>
	<brief_summary>Antiepileptic Drugs ( AEDs ) main treatment epilepsy ; however , limited number AEDs approve use monotherapy . The objective study evaluate efficacy BRV conversion partial onset seizure patient combination treatment monotherapy .</brief_summary>
	<brief_title>A Double-blind , Randomized Conversion Monotherapy Study Evaluate Efficacy Safety Brivaracetam Subjects ( ≥ 16 75 Years Old ) With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Subjects 16 75 year , inclusive Wellcharacterized focal epilepsy epileptic syndrome Subjects least 2 exceed 40 partial onset seizure , whether secondarily generalize per 4 week 8week Baseline Period Subjects stable dose least 1 2 concomitant Antiepileptic Drugs ( AEDs ) second AED ≤ 50 % minimum recommend maintenance dose Seizure type IA nonmotor seizure type History presence seizure occur frequently indistinctly separate reliably count 6 month precede Visit 1 Baseline Other serious uncontrolled disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Epilepsy ; Monotherapy</keyword>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>Adults Adolescents</keyword>
</DOC>